Page last updated: 2024-10-25

desipramine and Metabolism, Inborn Errors

desipramine has been researched along with Metabolism, Inborn Errors in 1 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Metabolism, Inborn Errors: Errors in metabolic processes resulting from inborn genetic mutations that are inherited or acquired in utero.

Research Excerpts

ExcerptRelevanceReference
" Her elimination half-life for desipramine was found to be greatly prolonged, at approximately 150 hours."1.27Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman. ( Dugas, JE; Glassman, JN; Loyd, DW; Tsuang, MT, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glassman, JN1
Dugas, JE1
Tsuang, MT1
Loyd, DW1

Other Studies

1 other study available for desipramine and Metabolism, Inborn Errors

ArticleYear
Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman.
    The Journal of nervous and mental disease, 1985, Volume: 173, Issue:9

    Topics: Depressive Disorder; Desipramine; Diphenhydramine; Female; Half-Life; Hospitalization; Humans; Kinet

1985